[EN] PYRROLIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY<br/>[FR] DÉRIVÉS DE PYRROLIDINE, COMPOSITIONS PHARMACEUTIQUES LES CONTENANT, ET LEUR UTILISATION EN THÉRAPIE
申请人:ABBVIE DEUTSCHLAND
公开号:WO2014140310A1
公开(公告)日:2014-09-18
The present invention relates to pyrrolidine derivatives of formula (I), or a physiologically tolerated salt thereof. The invention relates to pharmaceutical compositions comprising such pyrrolidine derivatives, and the use of such pyrrolidine derivatives for therapeutic purposes. The pyrrolidine derivatives are GlyT1 inhibitors.
The present disclosure relates to 1- or 2-(4-(aryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and 1- or 2-(4-(heteroaryloxy)-phenyl)ethylamino-, oxy- or sulfanyl)pteridines and their use as agrochemicals and animal health products.
Energetics of Halogen Bonding of Group 10 Metal Fluoride Complexes
作者:Torsten Beweries、Lee Brammer、Naseralla A. Jasim、John E. McGrady、Robin N. Perutz、Adrian C. Whitwood
DOI:10.1021/ja203320y
日期:2011.9.14
between Pt-X and Ni-X (X = F, C, P) bond lengths is greatest for X = F, consistent with F(2pπ)-Pt(5dπ) repulsive interactions. DFT calculations on the metal fluoride complexes show the very negative electrostatic potential around the fluoride. Calculations of the enthalpy of adduct formation show energies of -18.8 and -22.8 kJ mol(-1) for Ni and Pt complexes of types 5 and 4, respectively, in excellent